ShowcasesPricing
  1. US-listed companies
  2. Mersana Therapeutics, Inc.

Mersana Therapeutics, Inc.MRSN

Market cap
$331.16M
P/E ratio
Income statementBalance sheetCash flowOther
Raw aggregated data